Ciloxan: Uses, Dosage, and Side Effects Guide

Introduction

Ciloxan is an ophthalmic medication used for treating various bacterial eye infections, such as conjunctivitis and corneal ulcers. This comprehensive guide provides an overview of Ciloxan, including its chemical composition, uses, dosage, side effects, and other essential information.

Chemical Composition

The active ingredient in Ciloxan is ciprofloxacin hydrochloride, a synthetic fluoroquinolone antibiotic. Ciprofloxacin is a broad-spectrum antimicrobial agent that effectively targets various gram-negative and gram-positive bacteria.

Forms and Strengths

Ciloxan is available as a sterile ophthalmic solution and ointment. The solution is typically supplied in a concentration of 0.3% ciprofloxacin, while the ointment contains 0.3% ciprofloxacin in a white to off-white petrolatum base.

Eye Drops

Ciloxan eye drops are supplied in 2.5 mL, 5 mL, and 10 mL multi-dose containers. Each mL of the solution contains 3 mg of ciprofloxacin.

Ointment

Ciloxan ointment is available in a 3.5 g tube, containing 3.5 mg of ciprofloxacin per gram of ointment.

Uses and Indications

Ciloxan is primarily used for treating bacterial eye infections, such as:

Bacterial Conjunctivitis

Ciloxan is indicated for the treatment of bacterial conjunctivitis, commonly known as pink eye, caused by susceptible strains of bacteria, such as Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.

Corneal Ulcers

Ciloxan is also used to treat corneal ulcers caused by susceptible bacterial strains, including Pseudomonas aeruginosa and Serratia marcescens.

Mechanism of Action

As a fluoroquinolone antibiotic, ciprofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, repair, and recombination. By disrupting these processes, ciprofloxacin prevents bacterial growth and replication.

Dosage and Administration

The dosage and administration of Ciloxan depend on the type and severity of the eye infection being treated. Always follow the instructions provided by your healthcare provider or the product label.

Bacterial Conjunctivitis

For bacterial conjunctivitis, the recommended dosage is:

• Solution: Instill one or two drops into the affected eye(s) every two hours while awake for two days, then every four hours while awake for the next five days.
• Ointment: Apply a small amount (about 1/2 inch) into the affected eye(s) three times daily for seven days.

Corneal Ulcers

For corneal ulcers, the recommended dosage is:

• Solution: Instill two drops into the affected eye(s) every 15 minutes for the first six hours, then two drops every 30 minutes for the remainder of the first day. On the second day, instill two drops hourly, and then two drops every four hours for the next 12 days.
• Ointment: Apply a small amount (about 1/2 inch) into the affected eye(s) every 1 to 2 hours throughout the day and night for the first two days, then every 4 hours for the next 12 days.

Efficacy

Clinical studies have demonstrated the efficacy of Ciloxan in treating various bacterial eye infections. In a randomized, double-masked, multicenter clinical trial, Ciloxan ophthalmic solution was found to be as effective as tobramycin ophthalmic solution in treating bacterial conjunctivitis caused by susceptible strains.

Side Effects

Common side effects of Ciloxan include:

• Eye irritation, burning, or discomfort
• Temporary blurred vision
• Eyelid itching or swelling
• Tearing or eye discharge

Serious side effects, such as allergic reactions or tendon inflammation, are rare but require immediate medical attention.

Warnings and Precautions

Ciloxan should not be used in patients with known hypersensitivity to ciprofloxacin or other quinolone antibiotics. Patients should be advised to discontinue use and seek medical attention if they experience signs of an allergic reaction, such as rash, itching, or swelling.

Prolonged use of Ciloxan may result in the overgrowth of non-susceptible organisms, including fungi. If super infection occurs, discontinue use and institute alternative therapy.

Drug Interactions

Ciloxan may interact with other medications, including oral ciprofloxacin, which could increase the risk of side effects. Patients should inform their healthcare provider about all medications they are taking before starting treatment with Ciloxan.

Contraindications

Ciloxan is contraindicated in patients with a history of hypersensitivity to ciprofloxacin or any other component of the medication. It should not be used in patients who have a history of quinolone-associated tendinitis or tendon rupture.

Overdose

Overdose with Ciloxan is unlikely due to its topical administration. However, if overdose occurs, flush the affected eye(s) with water or saline solution. Seek medical attention if severe side effects occur.

Patient Counseling Information

Patients should be advised to:

• Wash hands before applying Ciloxan to avoid contamination
• Avoid touching the eye dropper or ointment tip to the eye or any other surface
• Remove contact lenses before applying Ciloxan and wait at least 15 minutes before reinserting them
• Complete the full course of treatment, even if symptoms improve
• Seek medical attention if symptoms worsen or do not improve after a few days of treatment

Comparative Analysis

Ciloxan is one of several ophthalmic antibiotics available for treating bacterial eye infections. Compared to other fluoroquinolones, such as ofloxacin and levofloxacin, Ciloxan has a similar spectrum of activity and efficacy. However, the choice of antibiotic may depend on factors such as patient allergies, cost, and regional bacterial resistance patterns.

Regulatory Status

Ciloxan was first approved by the U.S. Food and Drug Administration (FDA) in 1990 for the treatment of bacterial conjunctivitis and corneal ulcers. In recent years, generic versions of ciprofloxacin ophthalmic solution and ointment have become available, providing more affordable treatment options.

References and Further Reading

• Sharma, P. D., & Sharma, N. (2016). Ciprofloxacin: An Update. Journal of Clinical and Diagnostic Research, 10(6), FF01-FF04.
• Ciloxan (ciprofloxacin ophthalmic solution) [package insert]. Fort Worth, TX: Alcon Laboratories, Inc.; 2018.
• Leibowitz, H. M. (1991). Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. American Journal of Ophthalmology, 112(4), 34S-47S.